Clinical trials
6 active studies led by Septodont, of 11 in all
Source: ClinicalTrials.gov, Studies with Septodont (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 6Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Septodont or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Septodont
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
US drug approvals
6 approvals with a product on the US market
- Dyclopro ANDA200480 · approved 20 Nov 2018
- Prilocaine Hydrochloride And Epinephrine Bitartrate ANDA078959 · approved 30 Aug 2011
- Lidocaine ANDA040911 · approved 23 May 2011
- Prilocaine Hydrochloride ANDA079235 · approved 29 Sep 2010
- Oraverse NDA022159 · approved 9 May 2008
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
US device clearances
3 510(k) clearances and PMA approvals since 2015
- Bioroot Flow 0.5G, Bioroot Flow 2G K212283 · 16 Sep 2021
- Biodentine Xp 500, Biodentine Xp 200 K211799 · 10 Aug 2021
- Endosolv K172839 · 13 Feb 2018
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
US recalls
2 recalls since 2015 (2 for medicines)
Source: openFDA, FDA enforcement reports (recalls) naming the firm, since 2015. Retrieved 13 Nov 2026.
Trials over time
Studies Septodont leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Septodont or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Septodont: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Septodont is in.
From our blog
Stories on the topics Septodont works in.
Brain Cancer Diagnosis: Imaging and New Biomarkers
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Dental Care Services: Access, Cost and Prevention
Oral diseases affect nearly 3.7 billion people. Most are preventable, but dental care is often left out of…
Read
Breast Cancer Screening and Diagnosis: Closing the Gap
Breast cancer is the most common cancer in women worldwide. Finding it early saves lives, but access to…
Read